|Tested species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Recombinant human NALP3 (NACHT-, LRR-, and PYD-containing protein 3) (pyrin domain).|
|Storage buffer||tissue culture supernatant diluted in PBS|
|Contains||0.02% sodium azide|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Immunohistochemistry (Frozen) (IHC (F))||Assay-dependent|
|Western Blot (WB)||1:1000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA1-25943 detects NALP3 from human samples.
MA1-25943 has been successfully used in Western blot nd immunoprecipitation procedures. MA1-25943 has a predicted molecular weight of ~118kDa.
The MA1-25943 immunogen is recombinant human NALP3 (NACHT-, LRR-, and PYD-containing protein 3) (pyrin domain).
Store at 4°C. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
This gene encodes a pyrin like protein which contains a pyrin domain, a nucleotide binding site (NBS) domain, and a leucine rich repeat (LRR) motif. This protein interacts with apoptosis associated speck like protein containing a CARD. Proteins which contain the caspase recruitment domain, CARD, have been shown to be involved in inflammation and immune response. This protein may function as an activator of NF-kappaB signaling. The encoded protein may play a role in the regulation of inflammation and apoptosis. Mutations in this gene have been associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, and neonatal-onset multisystem inflammatory disease (NOMID). Two transcript variants encoding distinct isoforms have been identified for this gene.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.